Invesco Pharmaceuticals ETF
PJP
97 hedge funds and large institutions have $343M invested in Invesco Pharmaceuticals ETF in 2014 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 37 increasing their positions, 27 reducing their positions, and 8 closing their positions.
207% more call options, than puts
Call options by funds: $2.27M | Put options by funds: $738K
125% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 8
75% more funds holding in top 10
Funds holding in top 10: 4 → 7 (+3)
37% more repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 27
17% more capital invested
Capital invested by funds: $293M → $343M (+$49.4M)
8% more funds holding
Funds holding: 90 → 97 (+7)
0.27% less ownership
Funds ownership: 23.51% → 23.24% (-0.27%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PFG
Pacific Financial Group
Bellevue,
Washington
|
+$11.2M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$5.41M |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$5.36M |
| 4 |
SCM
Summit Capital Management
Seattle,
Washington
|
+$4.84M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$4.58M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$6.38M |
| 2 |
WA
WFG Advisors
Dallas,
Texas
|
-$2.43M |
| 3 |
MFS
MSI Financial Services
Springfield,
Massachusetts
|
-$1.9M |
| 4 |
Goldman Sachs
New York
|
-$1.8M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.79M |
PJP Hedge Fund Activity: Q4 2014 in Review
97 of the 3,765 institutional investors tracked by Wall St. Rank reported a position in Invesco Pharmaceuticals ETF (PJP) for Q4 2014, worth a combined $343M — up 17% from $293M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new PJP positions and 8 closed out — a net gain of 10 holders — while 37 added to existing stakes and 27 trimmed.
The largest buyer was Pacific Financial Group, adding an estimated $11.2M. The largest seller was Morgan Stanley, cutting an estimated $6.38M.
- 97 institutional investors held Invesco Pharmaceuticals ETF (PJP) as of Q4 2014, up from 90 in Q3 2014.
- Funds reported $343M of Invesco Pharmaceuticals ETF stock for Q4 2014, up 17% quarter-over-quarter.
- 18 funds opened new Invesco Pharmaceuticals ETF positions in Q4 2014 and 8 closed out, a net change of +10 holders.
- The largest Invesco Pharmaceuticals ETF buyer in Q4 2014 was Pacific Financial Group, an estimated $11.2M added.
- The largest Invesco Pharmaceuticals ETF seller in Q4 2014 was Morgan Stanley, an estimated $6.38M sold.
Based on aggregated 13F filings for Q4 2014.